Loading...
XNAS
OMDA
Market cap1.24bUSD
Oct 08, Last price  
20.82USD
1D
-0.34%
1Q
-10.57%
IPO
-7.88%
Name

Omada Health Inc

Chart & performance

D1W1MN
XNAS:OMDA chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
260m
+53.24%
89,185,000122,784,000169,800,000260,210,000
Net income
-13m
L-72.89%
-72,518,000-67,511,000-47,137,000-12,778,000
CFO
18m
P
-68,980,000-49,738,000-34,179,00018,252,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.

Key people

Lead Independent Chairman of the Board · since 2020
Wei-Li Shao
President
Sean Duffy
CEO, Co - Founder · since 2023
Steve Cook
Chief Financial Officer · since 2021
Nathan Salha
General Counsel
Casper De Clercq
General Partner, Norwest Venture Partners
William Dougherty
Chief Information Security Officer
Vijay Pande
General Partner, A16z
Member of the Board
Independent Director · since 2021
Independent Director · since 2024
Independent Director · since 2013
Adam Stavisky
Independent Director · since 2024
IPO date
Jun 06, 2025
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFY
2025‑122024‑122023‑122022‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT